N/A N=4 Treatment

Dietary Soy Isoflavones In Chronic Pancreatitis

Chronic Pancreatitis

Bottom Line

View on ClinicalTrials.gov: NCT02577640 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2021

Primary outcome: Primary: Dose Limiting Toxicities — 0; 0; 0; 0 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Soy bread (Dietary_supplement)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Ohio State University
Primary completion: Jul 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Dose Limiting Toxicities	0; 0; 0; 0	—
SECONDARY Pro-inflammatory Cytokines	2.67; 7.0; 2.38; 7.2	—

Summary

Dietary Soy Isoflavones in Chronic Pancreatitis: Investigating the Anti-inflammatory Effects of Food Innovation Science on Gastrointestinal Disease

Eligibility Criteria

Inclusion Criteria

Diagnosis of chronic pancreatitis by fulfilling one of the following clinical scenarios:
Presence of pancreatic calcifications
Suggestive for chronic pancreatitis - consistent EUS criteria or at least 3 abnormal side branches on pancreatic duct imaging
Indeterminate EUS findings for chronic pancreatitis with evidence of exocrine pancreatic insufficiency (EPI)
Age ≥18 years

Exclusion Criteria

Inability to provide written consent
Inability to comply with the study protocol
Soy allergy
Pancreatic cancer
History of prior pancreatic surgery (this does not include endoscopic therapies)
Comorbid diseases characterized by a chronic inflammatory state, including, but not limited to rheumatologic diseases, chronic kidney disease, extra-pancreatic malignancy
Pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02577640). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.